Dichoptic multifocal pupillography reveals afferent visual field defects in early type 2 diabetes

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 1, 2010, Pages 602-608

  Bell, Andrew ^a   James, Andrew C ^a   Kolic, Maria ^a   Essex, Rohan W ^b   Maddess, Ted ^a  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b CANBERRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DICHOPTIC MULTIFOCAL PUPILLOGRAPHY; FEMALE; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PUPIL REFLEX; PUPILLOGRAPHY; RECEIVER OPERATING CHARACTERISTIC; STIMULUS RESPONSE; VISUAL FIELD DEFECT; VISUAL STIMULATION; METHODOLOGY; MIDDLE AGED; PERIMETRY; PHYSIOLOGY; PUPIL; PUPIL DISEASE; VISUAL DISORDER; VISUAL FIELD;

DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIMETRY; PUPIL; PUPIL DISORDERS; ROC CURVE; VISION DISORDERS; VISUAL FIELDS;

EID: 75749132487     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-3659     Document Type: Article

References (51)

1. Dunstan DW, Zimmet PZ, Welborn TA, et al. The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care. 2002;25:829-834.
2. Centers for Disease Control. National Diabetes Fact Sheet. U.S. Atlanta: Department of Human Services; 2005.
3. Stratton IM, Kohner EM, Aldington SJ, et al. UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia. 2001;44:156-163.
4. Gardner TW, Antonetti DA, Barber AJ, LaNoue KF, Nakamura M. New insights into the pathophysiology of diabetic retinopathy: potential cell-specific therapeutic targets. Diabetes Technol Ther. 2000;2:601-608.
5. Trick GL, Trick LR, Kilo C. Visual field defects in patients with insulin-dependent and non-insulin-dependent diabetes. Ophthalmology. 1990;97:475-482.
6. Arend O, Remky A, Evans D, Stuber R, Harris A. Contrast sensitivity loss is coupled with capillary dropout in patients with diabetes. Invest Ophthalmol Vis Sci. 1997;30:1732-1737.
7. Afrashi F, Erakgun T, Kose S, Ardic K, Mentes J. Blue-on-yellow perimetry versus achromatic perimetry in type 1 diabetes patients without retinopathy. Diabetes Res Clin Pract. 2003;61:7-11.
8. Bengtsson B, Heijl A, Agardh E. Visual fields correlate better than visual acuity to severity of diabetic retinopathy. Diabetologia. 2005;48:2494-2500.
9. Stavrou EP, Wood JM. Central visual field changes using flicker perimetry in type 2 diabetes mellitus. Acta Ophthalmol Scand. 2005;83:574-580.
10. Agardh E, Stjernquist H, Heijl A, Bengtsson B. Visual acuity and perimetry as measures of visual function in diabetic macular oedema. Diabetologia. 2006;49:200-206.
11. Nitta K, Saito Y, Kobayashi A, Sugiyama K. Influence of clinical factors on blue-on-yellow perimetry for diabetic patients without retinopathy. Retina. 2006;26:797-802.
12. Birt CM, Shin DH, Samudrala V, Hughes BA, Kim C, Lee D. Analysis of reliability indices from Humphrey visual field tests in an urban glaucoma population. Ophthalmology. 1997;104:1126-1130.
13. Ivers RQ, Macaskill P, Cumming RG, Mitchell P. Sensitivity and specificity of tests to detect eye disease in an older population. Ophthalmology. 2001;108:968-975.
14. Pierre-Filho PTP, Schimiti RB, de Vasconcellos JPC, Costa VP. Sensitivity and specificity of frequency-doubling technology, tendency-oriented perimetry, SITA Standard and SITA Fast perimetry in perimetrically inexperienced individuals. Acta Ophthalmol Scand. 2006;84:345-350.
15. Keltner JL, Johnson CA, Beck RW, Cleary PA, Spurr JO. Quality control functions of the Visual Field Reading Center (VFRC) for the Optic Neuritis Treatment Trial (ONTT). Control Clin Trials. 1993;14:143-159.
16. Carpineto P, Ciancaglini M, Di Antonio L, Gavalas C, Mastropasqua L. Fundus microperimetry patterns of fixation in type 2 diabetic patients with diffuse macular edema. Retina. 2007;27:21-29.
17. Sutter E, Tran D. The field topography of ERG components in man, I. The photopic luminance response. Vision Res. 1992;32:433-446.
18. Bearse MA, Adams AJ, Han Y, et al. A multifocal electroretinogram model predicting the development of diabetic retinopathy. Prog Retin Eye Res. 2006;25:425-448.
19. Kurtenbach A, Langrova H, Zrenner E. Multifocal oscillatory potentials in type 1 diabetes without retinopathy. Invest Ophthalmol Vis Sci. 2000;41:3234-3241.
20. Bronson-Castain KW, Bearse MA Jr, Han Y, Schneck ME, Barez S, Adams AJ. Association between multifocal ERG implicit time delays and adaptation in patients with diabetes. Invest Ophthalmol Vis Sci. 2007;48:5250-5266.
21. Ng J, Bearse MA, Schneck ME, Barez S, Adams AJ. Local diabetic retinopathy prediction by multifocal ERG delays over 3 years. Invest Ophthalmol Vis Sci. 2008;49:1622-1628.
22. James AC. The pattern-pulse multifocal visual evoked potential. Invest Ophthalmol Vis Sci. 2003;44:879-890.
23. James AC, Ruseckaite R, Maddess T. Effect of temporal sparseness and dichoptic presentation on multifocal visual evoked potentials. Vis Neurosci. 2005;22:45-54.
24. Maddess T, James AC, Bowman EA. Contrast response of temporally sparse dichoptic multifocal visual evoked potentials. Vis Neurosci. 2005;22:153-162.
25. Maddess T, James AC, Ruseckaite R, Bowman EA. Hierarchical decomposition of dichoptic multifocal visual evoked potentials. Vis Neurosci. 2006;23:703-712.
26. Arvind H, Klistorner A, Graham SL, Grigg JR. Multifocal visual evoked responses to dichoptic stimulation using virtual reality goggles: multifocal VER to dichoptic stimulation. Doc Ophthalmol. 2006;112:189-199.
27. Ruseckaite R, Maddess T, Danta G, Lueck CJ, James AC. Sparse multifocal stimuli for the detection of multiple sclerosis. Ann Neurol. 2005;57:904-913.
28. Arvind H, Klistorner A, Graham S, et al. Dichoptic stimulation improves detection of glaucoma with multifocal visual evoked potentials. Invest Ophthalmol Vis Sci. 2007;48:4590-4596.
29. Bjerre A, Grigg JR, Parry NR, Henson DB. Test-retest variability of multifocal visual evoked potential and SITA standard perimetry in glaucoma. Invest Ophthalmol Vis Sci. 2004;45:4035-4040.
30. Kardon RH, Kirkali PA, Thompson HS. Automated pupil perimetry: pupil field mapping in patients and normal subjects. Ophthalmology. 1991;98:485-495; discussion 495-496.
31. Hong S, Narkiewicz J, Kardon RH. Comparison of pupil perimetry and visual perimetry in normal eyes: decibel sensitivity and variability. Invest Ophthalmol Vis Sci. 2001;42:957-965.
32. Tan L, Kondo M, Sato M, Kondo N, Miyake Y. Multifocal pupillary light response fields in normal subjects and patients with visual field defects. Vision Res. 2001;41:1073-1084.
33. Wilhelm H, Neitzel J, Wilhelm B, et al. Pupil perimetry using M-sequence stimulation technique. Invest Ophthalmol Vis Sci. 2000;41:1229-1238.
34. Maddess T, Bedford S, Goh XL, James AC. Multifocal pupillographic visual field testing in glaucoma. Clin Exp Ophthalmol. 2009;37:678-686.
35. James AC, Maddess T. Method and apparatus for assessing neural function by sparse stimuli. Australia Patent No. PQ 6465-00. 2000.
36. Lee YW, Schetzen M. Measurement of Wiener kernels of a nonlinear system by cross-correlation. Int J Control. 1965;2:237-254.
37. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29-36.
38. Johnson RA, Wichern DW. Applied Multivariate Statistical Analysis. 3rd ed. Englewood Cliffs: NJ: Prentice Hall; 1992.
39. Fawcett T. An introduction to ROC analysis. Pattern Recogn Lett. 2006;27:861-874.
40. Fletcher EL, Phipps JA, Ward MM, et al. Neuronal and glial cell abnormality as predictors of progression of diabetic retinopathy. Curr Pharm Design. 2007;13:2699-2712.
41. Dacey DM, Liao HW, Peterson BB, et al. Melanopsin-expressing ganglion cells in primate retina signal colour and irradiance and project to the LGN. Nature. 2005;433:749-754.
42. Dacey DM, Peterson BB, Robinson FR, Gamlin PD. Fireworks in the primate retina: in vitro photodynamics reveals diverse LGN-projecting ganglion cell types. Neuron. 2003;37:15-27.
43. Gamlin PD. The pretectum: connections and oculomotor-related roles. Prog Brain Res. 2006;151:379-405.
44. Graham SL, Klistorner AI, Grigg JR, Billson FA. Objective VEP perimetry in glaucoma: asymmetry analysis to identify early deficits. J Glaucoma. 2000;9:10-19.
45. Fortune B, Bearse MA Jr, Cioffi GA, Johnson CA. Selective loss of an oscillatory component from temporal retinal multifocal ERG responses in glaucoma. Invest Ophthalmol Vis Sci. 2002;43:2638-2647.
46. Hood DC, Zhang X, Rodarte C, et al. Determining abnormal interocular latencies of multifocal visual evoked potentials. Doc Ophthalmol. 2004;109:177-187.
47. Wong J, Molyneaux L, Constantino M, Twigg SM, Yue DK. Timing is everything: age of onset influences long-term retinopathy risk in type 2 diabetes, independent of traditional risk factors. Diabetes Care. 2008;31:1985-1990.
48. Sakata LM, Deleon-Ortega J, Arthur SN, Monheit BE, Girkin CA. Detecting visual function abnormalities using the Swedish interactive threshold algorithm and matrix perimetry in eyes with glaucomatous appearance of the optic disc. Arch Ophthalmol. 2007;125:340-345.
49. Cahill M, Eustace P, de Jesus V. Pupillary autonomic denervation with increasing duration of diabetes mellitus. Br J Ophthalmol. 2001;85:1225-1230.
50. Pittasch D, Behrans-Baumann W, Lobmann R, Lowe SW. Pupil signs of sympathetic autonomic neuropathy in patients with type 1 diabetes. Diabetes Care. 2002;25:1545-1550.
51. Anderson D. Automated Static Perimetry. St. Louis: Mosby Year Book; 1992.